Longer vs shorter blood thinners after a heart artery stent
Part of Heart & circulation clinical trials.
This study looks at whether taking a second blood thinner (clopidogrel) plus aspirin for a longer time helps prevent heart problems after a stent opens a fully blocked artery. It compares two durations of treatment to see which is better for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stent placed to open a completely blocked heart artery.
- You can take aspirin and another blood thinner (clopidogrel) for a long time.
- You are not allergic or sensitive to aspirin or clopidogrel.
- You are not currently taking prasugrel or ticagrelor (other antiplatelet medicines).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial compares two blood-thinning medicines—clopidogrel and aspirin—after you have finished a short period of dual therapy following a special type of drug-eluting heart stent. It may help find which medicine works better and is safer for preventing future heart problems.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
This trial tests if people who have been on two blood thinners (aspirin plus prasugrel or ticagrelor) for at least 90 days after getting a heart stent can safely switch to just one of those blood thinners. It aims to see if taking only one pill is as safe and effective as taking two.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
Hear when a new Chronic Total Occlusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.